Physician profile
Pushpa Reddy
NPI 1780766030
$1,039.66
in general payments reported to CMS, 2019-2025
15 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $59.76 · 2021: $44.83 · 2022: $193 · 2023: $118 · 2024: $141 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $242.90 | 2019-2025 | Rybelsus, Ozempic |
| Amgen INC. | $145.84 | 2019-2025 | Repatha |
| Allergan, INC. | $139.50 | 2019 | |
| Astellas Pharma US INC | $96.82 | 2020-2024 | Veozah, Myrbetriq |
| Lilly USA, LLC | $74.20 | 2022-2024 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $71.69 | 2022-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $62.40 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Novartis Pharmaceuticals Corporation | $53.64 | 2022 | |
| Sanofi-Aventis U.S. LLC | $39.47 | 2020-2021 | |
| Exact Sciences Corporation | $34.47 | 2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.23 | 2025 | Caplyta |
| Almatica Pharma LLC | $18.13 | 2025 | Teriparatide |
| Esperion Therapeutics, INC. | $15.25 | 2025 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.76 | 2021 | |
| Inari Medical, INC. | $13.36 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pushpa Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.